3 documents found, page 1 of 1
Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy ...
Marques,Vanessa Daccach; Passos,Giordani Rodrigues dos; Mendes,Maria Fernanda; Callegaro,Dagoberto; Lana-Peixoto,Marco AurélioABSTRACT The expanding therapeutic arsenal in multiple sclerosis (MS) has allowed for more effective and personalized treatment, but the choice and management of disease-modifying therapies (DMTs) is becoming increasingly complex. In this context, experts from the Brazilian Committee on Treatment and Research in Multiple Sclerosis and the Neuroimmunology Scientific Department of the Brazilian Academy of Neurolo...
Natalizumab treatment in multiple sclerosis: the experience from two Brazilian ...
Oliveira,Enedina Maria Lobato de; Simm,Renata Faria; Dasic,Gorana; Morais,Marília Mamprim de; Perreira,Samira Luiza dos Apostolos; Callegaro,DagobertoObjective Analyze the demographics, clinical characteristics, efficacy and safety of natalizumab treatment in Brazilian patients with multiple sclerosis (MS) followed up for at least 12 months, in two tertiary MS care centers in São Paulo.Method We evaluated the effect of natalizumab treatment on annualized relapse rate and disability progression in 75 patients with MS treated with natalizumab for at least 12 m...
Avaliação da disfunção erétil em pacientes com doença de Parkinson
Lucon,Marcos; Pinto,Adriana de Souza Santos; Simm,Renata Faria; Haddad,Mônica Santoro; Arap,Sami; Lucon,Antonio Marmo; Barbosa,Egberto ReisTrinta indivíduos portadores de doença de Parkinson (DP) e 30 indivíduos controle foram estudados prospectivamente, através do Índice Internacional de Função Erétil (IIFE) a propósito de avaliar a ocorrência de disfunção erétil (DE). Dos pacientes com DP (idade mediana de 59 anos), 46,66% referiram prática de atividade sexual. Todos parkinsonianos usavam medicação antiparkinsoniana. Neste grupo, 30,00% tinham h...